Avalo Therapeutics, Inc. (AVTX) has a market capitalization of $156.99M and trades at $13.90. The 52-week range is 3.39-20.72.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.4, Earnings Per Share (EPS) of $-5.84, annual revenue of $59K.
The stock has a beta of 0.94, operates in the Healthcare sector.
